Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms
Description
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. MeSH
Hierarchy View
Subtype Terms (5)
Esophageal Neoplasms
519 drugs (187 approved, 332 experimental)
Gastrointestinal Stromal Tumors
83 drugs (44 approved, 39 experimental)
Intestinal Neoplasms
457 drugs (234 approved, 223 experimental)
Stomach Neoplasms
616 drugs (209 approved, 407 experimental)
Zollinger-Ellison Syndrome
15 drugs (12 approved, 3 experimental)
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (7)
Phase 3 Indicated Drugs (14)
Phase 2 Indicated Drugs (51)
Organization Involved with Phase 4 Indications (18)
Organization Involved with Phase 3 Indications (23)
Organization Involved with Phase 2 Indications (103)
British Columbia Cancer Agency
Cancer Biotherapy Research Group
Cancer Therapeutics, Incorporated
Cancer Treatment Centers of America
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Department of Radiation Oncology
Federation Francophone de Cancerologie Digestive
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grupo Espanol de Tumores Neuroendocrinos (GETNE)
Hellenic Cooperative Oncology Group
Institut de Cancerologie de l'Ouest Paul Papin
National Cheng Kung University
National Institutes of Health (NIH)
Olivia Newton-John Cancer Research Institute
Shenzhen Hornetcorn Bio-technology Company, LTD
SSS International Clinical Research GmBH
Organization Involved with Phase 1 Indications (42)
Organization Involved with Other Experimental Indications (12)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
